Zavegepant for the acute treatment of migraine: look before leaping
Nat Rev Neurol
.
2023 Jun;19(6):329-330.
doi: 10.1038/s41582-023-00803-4.
Authors
Håkan Ashina
1
2
3
4
5
,
Peer Tfelt-Hansen
6
Affiliations
1
Harvard Medical School, Boston, MA, USA. hashina@bidmc.harvard.edu.
2
Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. hashina@bidmc.harvard.edu.
3
Department of Neurology, Danish Headache Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. hashina@bidmc.harvard.edu.
4
Department of Brain and Spinal Cord Injury, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. hashina@bidmc.harvard.edu.
5
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. hashina@bidmc.harvard.edu.
6
Department of Neurology, Danish Headache Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
PMID:
37012363
DOI:
10.1038/s41582-023-00803-4
No abstract available
Publication types
Comment
MeSH terms
Analgesics*
Humans
Migraine Disorders* / drug therapy
Substances
Analgesics